These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36735853)

  • 1. BC Clinical impact of medication reviews with follow-up in cardiovascular older patients in primary care: A cluster-randomized controlled trial.
    Martínez-Mardones F; Benrimoj SI; Ahumada-Canale A; Plaza-Plaza JC; Garcia-Cardenas V
    Br J Clin Pharmacol; 2023 Jul; 89(7):2131-2143. PubMed ID: 36735853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Review and Meta-Analysis of Medication Reviews Conducted by Pharmacists on Cardiovascular Diseases Risk Factors in Ambulatory Care.
    Martínez-Mardones F; Fernandez-Llimos F; Benrimoj SI; Ahumada-Canale A; Plaza-Plaza JC; S Tonin F; Garcia-Cardenas V
    J Am Heart Assoc; 2019 Nov; 8(22):e013627. PubMed ID: 31711390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effectiveness of Pharmacist Interventions on Cardiovascular Risk: The Multicenter Randomized Controlled RxEACH Trial.
    Tsuyuki RT; Al Hamarneh YN; Jones CA; Hemmelgarn BR
    J Am Coll Cardiol; 2016 Jun; 67(24):2846-54. PubMed ID: 27058907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
    Yu J; Shah BM; Ip EJ; Chan J
    J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.
    Jarab AS; Alqudah SG; Mukattash TL; Shattat G; Al-Qirim T
    J Manag Care Pharm; 2012 Sep; 18(7):516-26. PubMed ID: 22971205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and/or Dyslipidemia: Results of a Meta-Analysis.
    Weisser B; Predel HG; Gillessen A; Hacke C; Vor dem Esche J; Rippin G; Noetel A; Randerath O
    High Blood Press Cardiovasc Prev; 2020 Apr; 27(2):157-164. PubMed ID: 32219670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adding pharmacists to primary care teams reduces predicted long-term risk of cardiovascular events in type 2 diabetic patients without established cardiovascular disease: results from a randomized trial.
    Ladhani NN; Majumdar SR; Johnson JA; Tsuyuki RT; Lewanczuk RZ; Spooner R; Simpson SH
    Diabet Med; 2012 Nov; 29(11):1433-9. PubMed ID: 22486226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
    Palmer MJ; Barnard S; Perel P; Free C
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012675. PubMed ID: 29932455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of a pharmacist-led medication review with follow up for aged polypharmacy patients: A cluster randomized controlled trial.
    Varas-Doval R; Gastelurrutia MA; Benrimoj SI; García-Cárdenas V; Sáez-Benito L; Martinez-Martínez F
    Pharm Pract (Granada); 2020; 18(4):2133. PubMed ID: 33149794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacists as clinical care partners: How a pharmacist-led intervention is associated with improved medication adherence in older adults with common chronic conditions.
    Smith-Ray R; Feng L; Singh T; Rudkin K; Emmons S; Groves E; Kirkham H
    J Manag Care Spec Pharm; 2024 Apr; 30(4):345-351. PubMed ID: 38555630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high-performing health systems: the adherence and intensification of medications cluster randomized, controlled pragmatic trial.
    Heisler M; Hofer TP; Schmittdiel JA; Selby JV; Klamerus ML; Bosworth HB; Bermann M; Kerr EA
    Circulation; 2012 Jun; 125(23):2863-72. PubMed ID: 22570370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Dader Method for pharmaceutical care on control of blood pressure and total cholesterol in outpatients with cardiovascular disease or cardiovascular risk: EMDADER-CV randomized controlled trial.
    Amariles P; Sabater-Hernández D; García-Jiménez E; Rodríguez-Chamorro MÁ; Prats-Más R; Marín-Magán F; Galán-Ceballos JA; Jiménez-Martín J; Faus MJ
    J Manag Care Pharm; 2012 May; 18(4):311-23. PubMed ID: 22548691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cluster randomized controlled Trial to Evaluate an Ambulatory primary care Management program for patients with dyslipidemia: the TEAM study.
    Villeneuve J; Genest J; Blais L; Vanier MC; Lamarre D; Fredette M; Lussier MT; Perreault S; Hudon E; Berbiche D; Lalonde L
    CMAJ; 2010 Mar; 182(5):447-55. PubMed ID: 20212029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
    Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA
    Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial.
    Thom S; Poulter N; Field J; Patel A; Prabhakaran D; Stanton A; Grobbee DE; Bots ML; Reddy KS; Cidambi R; Bompoint S; Billot L; Rodgers A;
    JAMA; 2013 Sep; 310(9):918-29. PubMed ID: 24002278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials.
    Santschi V; Chiolero A; Burnand B; Colosimo AL; Paradis G
    Arch Intern Med; 2011 Sep; 171(16):1441-53. PubMed ID: 21911628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Management of Dyslipidaemia in Patients with Type 2 Diabetes Mellitus Receiving Lipid-Lowering Drugs: A Sub-Analysis of the CEPHEUS Findings.
    Shehab A; Al-Rasadi K; Arafah M; Al-Hinai AT; Al Mahmeed W; Bhagavathula AS; Al Tamimi O; Al Herz S; Al Anazi F; Al Nemer K; Metwally O; Alkhadra A; Fakhry M; Elghetany H; Medani AR; Yusufali AH; Al Jassim O; Al Hallaq O; Baslaib FOAS; Alawadhi M; Amin H; Al-Hashmi K; Oulhaj A
    Curr Vasc Pharmacol; 2018; 16(4):368-375. PubMed ID: 28677510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluations of pharmacist-led medication review in outpatients with hypertension, type 2 diabetes mellitus, and dyslipidaemia: a systematic review.
    Ahumada-Canale A; Quirland C; Martinez-Mardones FJ; Plaza-Plaza JC; Benrimoj S; Garcia-Cardenas V
    Eur J Health Econ; 2019 Sep; 20(7):1103-1116. PubMed ID: 31218580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving diabetic patients' adherence to treatment and prevention of cardiovascular disease (Office Guidelines Applied to Practice-IMPACT Study)-a cluster randomized controlled effectiveness trial.
    Olomu A; Kelly-Blake K; Hart-Davidson W; Gardiner J; Luo Z; Heisler M; Holmes-Rovner M
    Trials; 2022 Aug; 23(1):659. PubMed ID: 35971135
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.